Literature DB >> 15100267

Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells.

Steven J Bensinger1, Patrick T Walsh, Jidong Zhang, Martin Carroll, Ramon Parsons, Jeffrey C Rathmell, Craig B Thompson, Matthew A Burchill, Michael A Farrar, Laurence A Turka.   

Abstract

Despite expression of the high-affinity IL-2R, CD4(+)CD25(+) regulatory T cells (Tregs) are hypoproliferative upon IL-2R stimulation in vitro. However the mechanisms by which CD4(+)CD25(+) T cells respond to IL-2 signals are undefined. In this report, we examine the cellular and molecular responses of CD4(+)CD25(+) Tregs to IL-2. IL-2R stimulation results in a G(1) cell cycle arrest, cellular enlargement and increased cellular survival of CD4(+)CD25(+) T cells. We find a distinct pattern of IL-2R signaling in which the Janus kinase/STAT pathway remains intact, whereas IL-2 does not activate downstream targets of phosphatidylinositol 3-kinase. Negative regulation of phosphatidylinositol 3-kinase signaling and IL-2-mediated proliferation of CD4(+)CD25(+) T cells is inversely associated with expression of the phosphatase and tensin homologue deleted on chromosome 10, PTEN.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15100267      PMCID: PMC2842445          DOI: 10.4049/jimmunol.172.9.5287

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy.

Authors:  A D Wells; M C Walsh; J A Bluestone; L A Turka
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

2.  Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery.

Authors:  S R Datta; H Dudek; X Tao; S Masters; H Fu; Y Gotoh; M E Greenberg
Journal:  Cell       Date:  1997-10-17       Impact factor: 41.582

3.  Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase.

Authors:  N N Ahmed; H L Grimes; A Bellacosa; T O Chan; P N Tsichlis
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

4.  Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.

Authors:  S Sakaguchi; N Sakaguchi; M Asano; M Itoh; M Toda
Journal:  J Immunol       Date:  1995-08-01       Impact factor: 5.422

5.  Phosphatidylinositol 3-kinase links the interleukin-2 receptor to protein kinase B and p70 S6 kinase.

Authors:  K Reif; B M Burgering; D A Cantrell
Journal:  J Biol Chem       Date:  1997-05-30       Impact factor: 5.157

6.  Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F.

Authors:  P Brennan; J W Babbage; B M Burgering; B Groner; K Reif; D A Cantrell
Journal:  Immunity       Date:  1997-11       Impact factor: 31.745

7.  CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation.

Authors:  A Matsumoto; M Masuhara; K Mitsui; M Yokouchi; M Ohtsubo; H Misawa; A Miyajima; A Yoshimura
Journal:  Blood       Date:  1997-05-01       Impact factor: 22.113

8.  Interleukin-2 triggers a novel phosphatidylinositol 3-kinase-dependent MEK activation pathway.

Authors:  L M Karnitz; L A Burns; S L Sutor; J Blenis; R T Abraham
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

9.  The serine-rich cytoplasmic domain of the interleukin-2 receptor beta chain is essential for interleukin-2-dependent tyrosine protein kinase and phosphatidylinositol-3-kinase activation.

Authors:  I Merida; P Williamson; W A Kuziel; W C Greene; G N Gaulton
Journal:  J Biol Chem       Date:  1993-03-25       Impact factor: 5.157

10.  Intermediate affinity interleukin-2 receptor mediates survival via a phosphatidylinositol 3-kinase-dependent pathway.

Authors:  A González-García; I Mérida; C Martinez-A; A C Carrera
Journal:  J Biol Chem       Date:  1997-04-11       Impact factor: 5.157

View more
  113 in total

1.  New insights on OX40 in the control of T cell immunity and immune tolerance in vivo.

Authors:  Xiang Xiao; Weihua Gong; Gulcin Demirci; Wentao Liu; Silvia Spoerl; Xiufeng Chu; D Keith Bishop; Laurence A Turka; Xian C Li
Journal:  J Immunol       Date:  2011-12-05       Impact factor: 5.422

2.  Regulatory T cells require mammalian target of rapamycin signaling to maintain both homeostasis and alloantigen-driven proliferation in lymphocyte-replete mice.

Authors:  Ying Wang; Geoffrey Camirand; Yan Lin; Monica Froicu; Songyan Deng; Warren D Shlomchik; Fadi G Lakkis; David M Rothstein
Journal:  J Immunol       Date:  2011-01-26       Impact factor: 5.422

3.  Oestradiol potentiates the suppressive function of human CD4 CD25 regulatory T cells by promoting their proliferation.

Authors:  G Aleph Prieto; Yvonne Rosenstein
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

Review 4.  Interleukin-2 receptor signaling: at the interface between tolerance and immunity.

Authors:  Thomas R Malek; Iris Castro
Journal:  Immunity       Date:  2010-08-27       Impact factor: 31.745

5.  Scaffold protein Disc large homolog 1 is required for T-cell receptor-induced activation of regulatory T-cell function.

Authors:  Alexandra Zanin-Zhorov; Jiqiang Lin; Jose Scher; Sudha Kumari; David Blair; Keli L Hippen; Bruce R Blazar; Steven B Abramson; Juan J Lafaille; Michael L Dustin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

6.  Peripherally induced human regulatory T cells uncouple Kv1.3 activation from TCR-associated signaling.

Authors:  Mary C Reneer; Daniel J Estes; Alejandra C Vélez-Ortega; Andrea Norris; Michael Mayer; Francesc Marti
Journal:  Eur J Immunol       Date:  2011-09-19       Impact factor: 5.532

7.  Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells.

Authors:  Heather Kopf; Gonzalo M de la Rosa; O M Zack Howard; Xin Chen
Journal:  Int Immunopharmacol       Date:  2007-09-20       Impact factor: 4.932

8.  Malignant transformation of CD4+ T lymphocytes mediated by oncogenic kinase NPM/ALK recapitulates IL-2-induced cell signaling and gene expression reprogramming.

Authors:  Michal Marzec; Krzysztof Halasa; Xiaobin Liu; Hong Y Wang; Mangeng Cheng; Donald Baldwin; John W Tobias; Stephen J Schuster; Anders Woetmann; Qian Zhang; Suzanne D Turner; Niels Ødum; Mariusz A Wasik
Journal:  J Immunol       Date:  2013-11-11       Impact factor: 5.422

9.  Foxp3-mediated inhibition of Akt inhibits Glut1 (glucose transporter 1) expression in human T regulatory cells.

Authors:  Samik Basu; Britany Hubbard; Ethan M Shevach
Journal:  J Leukoc Biol       Date:  2014-12-09       Impact factor: 4.962

Review 10.  Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells.

Authors:  Prabhakaran Kumar; Shikha Saini; Saad Khan; Swarali Surendra Lele; Bellur S Prabhakar
Journal:  Cell Immunol       Date:  2018-09-29       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.